Mirum Pharmaceuticals Appoints Dr. Rob Myers as Chief Medical Officer
Mirum Pharmaceuticals Appoints Rob Myers, M.D. as Chief Medical Officer to Lead Global Medical and Clinical Development Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a rare disease-focused pharmaceutical company developing medicines for…
Encoded Therapeutics Presents Updated ETX101 Data from POLARIS Trials in Dravet Syndrome
Encoded Therapeutics Reports Durable Seizure Reduction and Neurodevelopmental Gains With ETX101 in Dravet Syndrome Encoded Therapeutics, Inc., a clinical-stage biotechnology company focused on developing precision genetic medicines for severe neurological…
Endeavor BioMedicines Presents New Imaging Data from Phase 2a Taladegib Trial in Idiopathic Pulmonary Fibrosis
Endeavor BioMedicines Reports Positive Quantitative Imaging Results for Taladegib in Idiopathic Pulmonary Fibrosis Endeavor BioMedicines, a clinical-stage biotechnology company focused on developing medicines with the potential to deliver transformational benefits…
Coya Therapeutics Announces Publication of Preclinical Data Supporting COYA 303’s Immunomodulatory Effects
Coya Therapeutics Publishes Preclinical Findings for COYA 303 in Neuroinflammation Coya Therapeutics, Inc. (NASDAQ: COYA), a clinical-stage biotechnology company focused on developing biologic therapies designed to enhance regulatory T-cell (Treg)…
Lineage Cell Therapeutics Announces Patent Issuance for AlloSCOPE™ 5D Manufacturing Platform
Lineage Cell Therapeutics Receives U.S. Patent Covering AlloSCOPE 5D Cell Manufacturing Platform Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company focused on developing novel allogeneic,…
Prilenia Appoints Frederick (Rick) Munschauer, MD, FAAN, as Chief Medical Officer
Prilenia Therapeutics Appoints Neurology Expert Rick Munschauer as Chief Medical Officer Prilenia Therapeutics B.V., a biopharmaceutical company focused on developing potential treatments for neurodegenerative diseases, has announced the appointment of…
RiboX Therapeutics Receives FDA RMAT Designation for RXRG001 for Radiation-Induced Xerostomia
RiboX Therapeutics Receives FDA RMAT Designation for RXRG001 in Radiation-Induced Xerostomia RiboX Therapeutics, a clinical-stage biotechnology company focused on discovering and developing fully engineered circular RNA (circRNA) therapeutics, announced that…
Agilent Announces Board Chair Retirement and Appoints Glenn Boehnlein to Board of Directors
Agilent Technologies Announces Board Leadership Transition and Appointment of Glenn Boehnlein Agilent Technologies Inc. (NYSE: A) has announced a series of leadership changes to its board of directors, marking an…
Compass Pathways to Launch U.S. HCP Campaign and Present New HEOR Data at Psych Congress 2026
Compass Pathways to Highlight Treatment-Resistant Depression Research and Launch New HCP Education Campaign at Psych Congress 2026 Compass Pathways plc (Nasdaq: CMPS), a biotechnology company focused on developing new treatment…
Teleflex Appoints Sean M. Salmon to Board of Directors
Teleflex Appoints Sean M. Salmon to Board of Directors to Support Strategic Growth Teleflex Incorporated, a global provider of medical technologies, has announced the appointment of Sean M. Salmon to…
Alzheon Reports Positive ALZ-801 Biomarker and Clinical Outcomes in Early Alzheimer’s Disease
Alzheon Reports Biomarker Findings Supporting Potential Disease-Modifying Effects of Valiltramiprosate in Early Alzheimer’s Disease Alzheon, Inc., a clinical-stage biopharmaceutical company focused on developing investigational therapies and diagnostic assays for Alzheimer’s…
Dunbar Pharma to Highlight European Dronabinol Supply Capabilities at expopharm 2026 in Munich
Dunbar Pharmaceuticals to Showcase Pharmaceutical-Grade Plant-Derived Dronabinol at expopharm 2026 Dunbar Pharmaceuticals, also known as Dunbar Pharma, is set to participate in expopharm 2026, one of Europe’s leading trade fairs…